The Institute of Medicine has released the summary of a workshop it hosted last July to discuss the economic issues likely to arise in the age of genomic medicine.

The workshop brought together economists, regulators, payors, researchers, patients, and other stakeholders to discuss various economic factors likely to influence the integration of genomic data into healthcare.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Cell this week: dynamics of protein profusion and localization, melanoma classification schemes, and more.

A company says it can generate likenesses of people based on their genetic profiles.

IBM's Watson is learning how to treat leukemia as a fellow at the MD Anderson Cancer Center, according to the Washington Post.

In PNAS this week: ancestry and admixture in Brazilians, characterization of novel double-stranded RNA mycovirus, and more.